Guardion Health Sciences Inc
NASDAQ:GHSI
Income Statement
Earnings Waterfall
Guardion Health Sciences Inc
Revenue
|
12.2m
USD
|
Cost of Revenue
|
-6.9m
USD
|
Gross Profit
|
5.4m
USD
|
Operating Expenses
|
-9.3m
USD
|
Operating Income
|
-3.9m
USD
|
Other Expenses
|
4.1m
USD
|
Net Income
|
158k
USD
|
Income Statement
Guardion Health Sciences Inc
Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
+33%
|
0
N/A
|
0
+17%
|
0
+21%
|
0
+18%
|
0
+15%
|
0
+91%
|
1
+30%
|
1
+28%
|
1
+32%
|
1
-2%
|
1
+4%
|
1
+4%
|
1
-13%
|
1
+1%
|
1
+1%
|
2
+102%
|
2
+5%
|
2
-2%
|
2
-1%
|
2
+2%
|
5
+153%
|
7
+51%
|
9
+30%
|
11
+22%
|
11
-4%
|
11
+1%
|
12
+7%
|
11
-4%
|
12
+6%
|
12
+2%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||
Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(1)
|
(1)
|
(2)
|
(4)
|
(4)
|
(5)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
|
Gross Profit |
0
N/A
|
0
+67%
|
0
N/A
|
0
+40%
|
0
+14%
|
0
+13%
|
0
+22%
|
0
+136%
|
0
+31%
|
0
+29%
|
1
+32%
|
1
-7%
|
1
+7%
|
1
+5%
|
1
-13%
|
1
+6%
|
1
-2%
|
2
+262%
|
2
+3%
|
1
-73%
|
1
+71%
|
(0)
N/A
|
1
N/A
|
3
+166%
|
4
+32%
|
5
+20%
|
5
-6%
|
5
-3%
|
5
+6%
|
5
-3%
|
5
+8%
|
5
+8%
|
|
Operating Income | |||||||||||||||||||||||||||||||||
Operating Expenses |
(4)
|
(5)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(7)
|
(8)
|
(8)
|
(7)
|
(6)
|
(7)
|
(8)
|
(10)
|
(12)
|
(10)
|
(10)
|
(9)
|
(10)
|
(11)
|
(12)
|
(14)
|
(15)
|
(15)
|
(13)
|
(12)
|
(11)
|
(10)
|
(10)
|
(9)
|
|
Selling, General & Administrative |
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(4)
|
(5)
|
(7)
|
(7)
|
(7)
|
(6)
|
(5)
|
(7)
|
(8)
|
(9)
|
(10)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(12)
|
(13)
|
(14)
|
(15)
|
(13)
|
(12)
|
(11)
|
(10)
|
(9)
|
(9)
|
|
Research & Development |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Depreciation & Amortization |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(4)
N/A
|
(5)
-24%
|
(4)
+28%
|
(4)
-1%
|
(4)
-5%
|
(4)
+4%
|
(4)
-19%
|
(5)
-19%
|
(7)
-32%
|
(7)
-7%
|
(7)
+6%
|
(6)
+12%
|
(5)
+19%
|
(7)
-30%
|
(8)
-20%
|
(9)
-15%
|
(12)
-30%
|
(8)
+32%
|
(8)
+4%
|
(9)
-11%
|
(9)
-5%
|
(11)
-19%
|
(11)
-5%
|
(10)
+6%
|
(10)
+1%
|
(10)
+7%
|
(9)
+10%
|
(7)
+16%
|
(6)
+16%
|
(5)
+11%
|
(5)
+18%
|
(4)
+13%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(3)
|
(3)
|
(2)
|
3
|
5
|
5
|
5
|
4
|
|
Non-Reccuring Items |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
(2)
|
(2)
|
(0)
|
0
|
(2)
|
(2)
|
(14)
|
(14)
|
(12)
|
(12)
|
(10)
|
(10)
|
(10)
|
(10)
|
(0)
|
|
Total Other Income |
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(5)
N/A
|
(6)
-29%
|
(5)
+23%
|
(6)
-24%
|
(5)
+5%
|
(5)
+9%
|
(5)
-9%
|
(5)
+2%
|
(7)
-31%
|
(8)
-14%
|
(8)
-7%
|
(8)
+8%
|
(7)
+12%
|
(8)
-18%
|
(8)
-3%
|
(11)
-31%
|
(12)
-9%
|
(10)
+20%
|
(9)
+3%
|
(9)
+7%
|
(9)
-4%
|
(13)
-43%
|
(14)
-7%
|
(25)
-82%
|
(27)
-11%
|
(25)
+10%
|
(22)
+9%
|
(15)
+33%
|
(11)
+27%
|
(10)
+5%
|
(9)
+11%
|
0
N/A
|
|
Net Income | |||||||||||||||||||||||||||||||||
Income from Continuing Operations |
(5)
|
(6)
|
(5)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(7)
|
(8)
|
(8)
|
(8)
|
(7)
|
(8)
|
(8)
|
(11)
|
(12)
|
(10)
|
(9)
|
(9)
|
(9)
|
(13)
|
(14)
|
(25)
|
(27)
|
(25)
|
(22)
|
(15)
|
(11)
|
(10)
|
(9)
|
0
|
|
Net Income (Common) |
(5)
N/A
|
(6)
-29%
|
(5)
+20%
|
(7)
-34%
|
(6)
+3%
|
(6)
+7%
|
(6)
-10%
|
(6)
+4%
|
(8)
-25%
|
(9)
-11%
|
(9)
-3%
|
(8)
+13%
|
(7)
+12%
|
(8)
-18%
|
(8)
-3%
|
(11)
-31%
|
(12)
-9%
|
(10)
+20%
|
(9)
+3%
|
(9)
+7%
|
(9)
-4%
|
(13)
-43%
|
(14)
-7%
|
(25)
-82%
|
(27)
-11%
|
(25)
+10%
|
(22)
+9%
|
(16)
+29%
|
(12)
+25%
|
(11)
+4%
|
(10)
+11%
|
0
N/A
|
|
EPS (Diluted) |
-58.62
N/A
|
-75.87
-29%
|
-60.87
+20%
|
-93.42
-53%
|
-79.25
+15%
|
-73.87
+7%
|
-72
+3%
|
-69.11
+4%
|
-60
+13%
|
-66.61
-11%
|
-68.46
-3%
|
-110.99
-62%
|
-97.57
+12%
|
-57.64
+41%
|
-69.24
-20%
|
-90.66
-31%
|
-45.57
+50%
|
-32.79
+28%
|
-31.93
+3%
|
-29.55
+7%
|
-20.67
+30%
|
-25.95
-26%
|
-27.73
-7%
|
-52.65
-90%
|
-35.08
+33%
|
-19.94
+43%
|
-18.16
+9%
|
-14.15
+22%
|
-9.32
+34%
|
-8.9
+5%
|
-7.96
+11%
|
0.12
N/A
|